Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

5(83.3%)

Phase 1

1(16.7%)

6Total

N/A(5)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT05050292Not ApplicableUnknown

Cognitive Stimulation and Sleep Quality. An Innovative Intervention for Insomnia

Role: lead

NCT05582603Phase 1Unknown

Safety and Dosage of a Computerized Cognitive Training Program for Cognitive Dysfunction After COVID-19

Role: lead

NCT05571852Not ApplicableCompleted

Personalized Computerized Training Program for Cognitive Dysfunction After COVID-19

Role: lead

NCT05409248Not ApplicableUnknown

Cognitive Stimulation and Chemobrain. An Innovative Intervention for Cancer Survivors

Role: lead

NCT04299672Not ApplicableCompleted

Cervical Functionality and Posture (CERFUPOS)

Role: lead

NCT04110509Completed

Fragility and Programmed Cardiovascular Surgery (EcoSarco)

Role: lead

NCT03516344Not ApplicableCompleted

Effect of Osteopathic Manipulations on Portal Venous Flow

Role: lead

All 7 trials loaded